DAnish Nausea Study In Advanced Cancer-Epidemiology: A Danish Multicenter Trial to Investigate the Prevalence and Treatment of Nausea and/or... | NCT02980289 | Trialant
CompletedObservationalUpdated Aug 23, 2018
DAnish Nausea Study In Advanced Cancer-Epidemiology: A Danish Multicenter Trial to Investigate the Prevalence and Treatment of Nausea and/or Vomiting in Patients With Advanced Cancer.
ClinicalTrials.gov ID
NCT02980289
Lead Sponsor
Signe HarderOTHER
Overall Status
Completed
Study Type
Observational
Enrollment
821Actual
Last Update Posted
Aug 23, 2018Actual
Start Date
Feb 2016
Primary Completion Date
Jul 1, 2018Actual
Completion Date
Jul 1, 2018Actual
Brief Summary
The study aims to investigate the prevalence and treatment of nausea and/or vomiting in patients with advanced cancer not receiving chemotherapy or irradiation.
Advanced Cancer
Nausea
Emesis
No interventions
There are no interventions for this study.
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Advanced cancer
Age ≥ 18 years
Ability to read and understand the forms required for the study
Life-expectancy more than 2 weeks.
Nausea score ≥ 'a little' on the extended EORTC QLQ-C15-PAL (item 9)
Exclusion Criteria:
Surgery to the brain or abdomen within the last 2 weeks or exposure to general anesthesia within the last 4 days.
Chemotherapy or radiation therapy within the last 4 weeks
Symptoms of increased intracranial pressure or cerebral metastasis. If this is suspected, a normal MRI scan of the cerebrum is needed before inclusion
Radiologically confirmed ileus, or strong clinical suspicion evaluated by the study Investigator